Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trials
-
Published:2024-08
Issue:8
Volume:9
Page:103663
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Lordick F.,
Van Cutsem E.,
Shitara K.,
Xu R.-H.,
Ajani J.A.,
Shah M.A.,
Oh M.,
Ganguli A.,
Chang L.,
Rhoten S.,
Bhattacharya P.,
Matsangou M.,
Park J.W.,
Pophale R.,
Ranganath R.,
Kang Y.-K.ORCID
Funder
Astellas Pharma Inc